| Document Date: 2013-03-30 23:57:21
Open Document File Size: 137,33 KBShare Result on Facebook
City CAMBRIDGE / / Company Tetragenetics Inc. / Amgen Exclusive Research License / Immunogen / / / Event Business Partnership / / IndustryTerm biotechnology / conventional systems / platform technologies / technology access / discovery technology / pharmaceutical / / Person Suzanne Gibbons-Neff / John Reilly / V / Ted Clark / John Reilly V / / / Position Chief Scientific Officer / V.P. Business Development jreilly@tetragenetics.com / V.P. Business Development / / ProvinceOrState Massachusetts / / Technology drug discovery / antibodies / biotechnology / discovery technology / platform technologies / / URL www.tetragenetics.com / /
SocialTag |
Tetragenetics Announces Collaboration with Amgen Exclusive Research License Of Tetragenetics’ Technology For Surface Antigen Drug Target CAMBRIDGE, Mass. April 2, 2013. Tetragenetics Inc. a 2012 Gates Foundation Phase